MORPHOSYSMORPHOSYSMORPHOSYS

MORPHOSYS

No trades
See on Supercharts
Market capitalization
‪2.56 B‬EUR
−5.70EUR
‪−189.73 M‬EUR
‪238.28 M‬EUR
‪37.65 M‬
Beta (1Y)
−0.29

About MORPHOSYS

CEO
Jean-Paul Kress
Headquarters
Planegg
Employees (FY)
564
Founded
1992
ISIN
DE0006632003
FIGI
BBG000C68WT2
MorphoSys AG is a biopharmaceutical company, which engages in the development and commercialization of cancer therapeutics. Its clinical programs focus on Pelabresib and Tulmimetostat. The company was founded by Andreas Pluckthun and Simon E. Moroney in July 1992 and is headquartered in Planegg, Germany.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of MOR is 67.70 EUR — it has decreased by 0.37% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on XETR exchange MORPHOSYS stocks are traded under the ticker MOR.
MORPHOSYS is going to release the next earnings report on Apr 29, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for MORPHOSYS has a max estimate of 68.00 EUR and a min estimate of 40.00 EUR.
MOR earnings for the last quarter are −3.50 EUR whereas the estimation was −2.13 EUR which accounts for −64.22% surprise. Estimated earnings for the next quarter are −1.88 EUR. See more details about MORPHOSYS earnings.
MORPHOSYS revenue for the last quarter amounts to ‪63.80 M‬ EUR despite the estimated figure of ‪56.73 M‬ EUR. In the next quarter revenue is expected to reach ‪59.38 M‬ EUR.
Yes, you can track MORPHOSYS financials in yearly and quarterly reports right on TradingView.
Like other stocks, MOR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MORPHOSYS stock right from TradingView charts — choose your broker and connect to your account.
MOR reached its all-time high on Jan 13, 2020 with the price of 146.30 EUR, and its all-time low was 1.55 EUR and was reached on Dec 20, 2002.
See other stocks reaching their highest and lowest prices.
As of Apr 16, 2024, the company has 564.00 employees. See our rating of the largest employees — is MORPHOSYS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MORPHOSYS EBITDA is ‪−240.32 M‬ EUR, and current EBITDA margin is −95.29%. See more stats in MORPHOSYS financial statements.